Key result
Repeated paclitaxel drug-coated balloon angioplasty triggers recurrent severe hypersensitivity reactions and shock.
Why the study?
Paclitaxel drug-coated balloons are widely used for selected coronary lesions, but severe hypersensitivity reactions during coronary P-DCB angioplasty are rarely recognized.
Case Report (n=1)
No
This case highlights that severe, potentially life-threatening hypersensitivity reactions can occur during coronary paclitaxel drug-coated balloon angioplasty and may be underrecognized.
Hypersensitivity may complicate repeated paclitaxel DCB use; this case leaves open incidence and risk stratification needs.
BACKGROUND: Paclitaxel drug-coated balloons (P-DCBs) are widely used for selected coronary lesions, but severe hypersensitivity reactions during coronary P-DCB angioplasty are rarely recognized. We report a rare case of recurrent severe hypersensitivity reaction temporally associated with repeated coronary P-DCB (Note: For ease of expression, the "Paclitaxel-eluting balloon" used in this case will be uniformly referred to as "P-DCB".) angioplasty. CASE PRESENTATION: A 60-year-old man with multivessel coronary artery disease developed two episodes of acute hypotension, transient loss of consciousness, and subsequent cutaneous manifestations after repeated coronary P-DCB angioplasty. During the first procedure, shock-level hypotension occurred 53 min after paclitaxel release, followed by transient syncope and urticarial rash. During the second procedure, blood pressure and heart rate began to decline 16 min after paclitaxel release, and shock-level hypotension with transient syncope, limb convulsions, urinary incontinence, vomiting, pruritus, and erythema occurred thereafter. The patient recovered after prompt hemodynamic support, atropine, corticosteroid administration, and fluid infusion. CONCLUSION: This case highlights a potentially underrecognized complication and underscores the need for heightened vigilance during coronary P-DCB therapy.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) conducted a case report in Multivessel coronary artery disease (n=1). Paclitaxel drug-coated balloon (P-DCB) angioplasty was evaluated on Severe hypersensitivity reaction. Repeated coronary paclitaxel drug-coated balloon angioplasty in a 60-year-old man resulted in recurrent severe hypersensitivity reactions characterized by shock-level hypotension and transient syncope.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: